The drug, which Lilly has already submitted to the FDA for review, also beat Novos semaglutide at reducing A1C in a head-to-head trial for type 2 diabetes in September
Wegovy injections are FDA approved for adults and children 12 years and older with a body mass index of 30 or more, or patients with additional conditions, such as high cholesterol, hypertension, sleep apnea, type 2 diabetes, heart disease, or other chronic metabolic illnesses, who have body mass index of 27 or more
Glucose and glucoincretin peptides synergize to induce c fos , c jun , junB , zif 268, and nur 77 gene expression in pancreatic (INS1) cells
Why Choose Pure Harmony Med Spa